Acuta Capital Partners, LLC Dice Therapeutics, Inc. Transaction History

Acuta Capital Partners, LLC

  • $92.9 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$14.97 - $22.65 $100,299 - $151,755
6,700 New
6,700 $136,000
Q2 2022

Aug 15, 2022
SELL
$13.19 - $22.1 $494,625 - $828,750
-37,500 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$14.54 - $25.02 $545,250 - $938,250
37,500 New
37,500 $717,000

Others Institutions Holding DICE

# of Institutions
3
Shares Held
17.7K
Call Options Held
13K
Put Options Held
0
View Full List

About DICE Therapeutics, Inc.

DICE Quotes by TradingView
  • Ticker DICE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,430,000
  • Description
  • DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...
More about DICE
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email